September 17-19, 2018
Ocean Place Resort, Long Branch, NJ

> 2017 Exhibitors

> 2016 Exhibitors

> 2014 Exhibitors

Download Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2018 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of September 20, 2018

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

Daikin Chemical Europe
DavosPharma
Dipharma/Kalexsyn
Domainex
Dottikon
Drug Discovery Alliances

Daikin Chemical Europe, Booth 20 [ company website ]

Daikin has been a world leader in the development, manufacture and sales of fluoropolymers and chemistry since 1924. Headquartered in Osaka, Japan, Daikin is renowned for innovation, quality and commitment. As the world changes, Daikin is meeting the challenges with technology that makes a difference. We have been in the forefront of the fluorocarbon industry not just with constant innovation in the products we develop, but the service and support behind them.

Daikin’s fluoropolymers and chemicals, with their wide range of unique properties and Daikin’s products are ideally suited for use in aerospace, architecture, automotive, consumer cookware, energy storage, filtration, home goods, industry, medical, nonwovens, optics & displays, paper & packaging, oil & gas, renewable energy, semiconductor, textile & fabric treatments and wire & cable.

 

DavosPharma, Booth 99

We provide custom chemistry (novel raw materials, GMP intermediates, regulatory starting materials & APIs) and custom dosage forms (parenterals and orals), with supporting development, analytics, stability and regulatory documentation. We have successfully leveraged thirty-seven years of custom manufacturing experience, forming global strategic alliances with well-vetted, cGMP custom manufacturers in the EU, North America and Asia. Our expertise enables us to match your particular need with the suppl

Dipharma/Kalexsyn, Booth 66

Kalexsyn’s world-class scientists provide hit validation, lead optimization and solving tough synthetic problems. We also provide stable label synthesis and custom synthesis. Our process route development, process improvement and early API team is comprised of a group of senior scientists formerly with large pharma API teams. We offer clients an outstanding CRO experience with fixed quote, tailored short and long term FTE arrangements. Kalexsyn is privately owned with research laboratories in

Dipharma Group is highlighted on the market as one of the major European players in the field of Bulk Active Pharmaceutical Ingredients having a portfolio of about 60 APIs, with DMFs filed worldwide. We serve top ranking pharmaceutical companies in Europe, U.S.A. and Japan, supported by a fully equipped R&D Centre, consisting of more than 40 qualified researchers.

Modern laboratory equipment and one dedicated pilot plant enable us to develop and optimize complex chemical synthetic processes. Our three plants, operating in full cGMP, with a total capacity of about 550 m3, have been regularly inspected by US FDA through the years. All above competencies and capabilities make Dipharma the right partner for Custom Synthesis.

Our core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenations, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.”

Domainex, Booth 29 [ company website ]

Domainex is Europe’s fastest growing fully integrated drug discovery service company. Based near Cambridge, UK, with offices in Boston, MA and San Diego, CA, we work with pharmaceutical, biotechnology, academic and patient foundations globally. Domainex provides highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of targets. Our highly experienced molecular biologists, medicinal, computation and analytical chemists have a strong success record in drug discovery, delivering an average of one candidate drug every year.

Dottikon, Booth 31

DOTTIKON EXCLUSIVE SYNTHESIS is specialized on hazardous chemistry, with a focus on strongly exothermic reactions as well as unstable, highly reactive, or high-potent compounds or mixtures. DOTTIKON ES manufactures high-quality intermediates and exclusive APIs, from the kilogram to the multi-ton range, for the world's leading pharmaceutical and chemical industries. Hazardous reactions often allow to shorten production and synthesic procedures, reduce waste, improve yields, selectivity, and purity, an

Drug Discovery Alliances, Booth 129